DEVICES & DIGITAL

External trigeminal nerve stimulation (eTNS) for ADHD

A prescription device worn at night that stimulates a nerve in the forehead.

How it works

A small patch on the forehead delivers low-level stimulation to the trigeminal nerve while a child sleeps.

What the evidence says, use by use

Evidence is specific to the condition, population and—for devices—the exact product. One label never covers everything.

ADHD: Reducing ADHD symptoms

Emerging / limited
Who was studied / who it’s for: Children 7–12 not taking ADHD medicationRegulatory status: FDA De Novo (2019), prescription only.What this label means: Early, small or mixed studies. Interesting, but not equivalent to established care.

FDA permitted marketing in 2019 based on a small trial (62 children); benefits are modest and evidence is limited compared with established treatments.

Sources: FDA (2019)

Who usually provides it

Prescribing clinicians.

Cautions & things to know

  • Not a replacement for established ADHD care.
  • Not for children with implanted devices.

Questions for a clinician

Conversation prompts, not a treatment plan.

  • How does this compare with established options for this child?

Educational, not medical advice. NeuroCoach is an educational and care-navigation resource, not a medical provider. Information about medications, supplements, therapies, devices, clinical trials and community experiences is provided for education and exploration and is not a recommendation, diagnosis or treatment plan. Evidence varies substantially among interventions. Decisions about medical or mental-health treatment should be made with an appropriately qualified healthcare professional. Do not start, stop or change medication, supplements or treatment based solely on information found here.

Sources

Sources checked October 5, 2026. Links support this page; they don’t imply endorsement of NeuroCoach.

  1. FDA permits marketing of first medical device for treatment of ADHD FDA (2019)